Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Poorva Bindal

4PUBLICATIONS

5CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 12, 2023

Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.

Poorva Bindal, Mimi Najjar, Kelly Koehn

|May 12, 2020

Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab.

Nikhila Kethireddy, Steffi Thomas, Poorva Bindal

|Mar 27, 2019

Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor.

Vinay Mathew Thomas, Poorva Bindal, Swetha Ann Alexander

|Feb 15, 2019

Treatment exceeds expectations in a patient with non-small cell lung adenocarcinoma with an EGFR exon 20 mutation.

Agnes McAuliffe, Poorva Bindal, Meredith Haley

Pageof 1

Frequent Collaborators

1 joint publications

Agnes McAuliffe

1 joint publications

Vinay Mathew Thomas

1 joint publications

Nikhila Kethireddy

1 joint publications

Steffi Thomas

1 joint publications

Ghulam Rehman Mohyuddin

Frequent Collaborators

1 joint publications

Agnes McAuliffe

1 joint publications

Vinay Mathew Thomas

1 joint publications

Nikhila Kethireddy

1 joint publications

Steffi Thomas

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on : May 29, 2020

See more related videos

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on : May 29, 2020

See more related videos